Diagnosis and Prognosis of COVID-19 Disease Using Routine Blood Values and LogNNet Neural Network
Since February 2020, the world has been engaged in an intense struggle with
the COVID-19 dis-ease, and health systems have come under tragic pressure as
the disease turned into a pandemic. The aim of this study is to obtain the most
effective routine blood values (RBV) in the diagnosis and prognosis of COVID-19
using a backward feature elimination algorithm for the LogNNet reservoir neural
network. The first dataset in the study consists of a total of 5296 patients
with the same number of negative and positive COVID-19 tests. The LogNNet-model
achieved the accuracy rate of 99.5% in the diagnosis of the disease with 46
features and the accuracy of 99.17% with only mean corpuscular hemoglobin
concentration, mean corpuscular hemoglobin, and activated partial prothrombin
time. The second dataset consists of a total of 3899 patients with a diagnosis
of COVID-19 who were treated in hospital, of which 203 were severe patients and
3696 were mild patients. The model reached the accuracy rate of 94.4% in
determining the prognosis of the disease with 48 features and the accuracy of
82.7% with only erythrocyte sedimentation rate, neutrophil count, and C
reactive protein features. Our method will reduce the negative pressures on the
health sector and help doctors to understand the pathogenesis of COVID-19 using
the key features. The method is promising to create mobile health monitoring
systems in the Internet of Things.